Skip to main content

Month: August 2023

How Will the Biopsy Devices Market Transform Itself into a USD 4.20 Billion Powerhouse by 2032?

Biopsy devices are medical instruments or tools designed and used by healthcare professionals to extract samples of tissue or cells from a patient’s body for diagnostic or investigative purposes Vancouver, Aug. 10, 2023 (GLOBE NEWSWIRE) — Emergen research is one of the pioneers in providing strategic insights for emerging and disruptive technologies which are supposed to show exponential growth in the near future., has released a report that delves deep into the dynamic landscape of the Biopsy Devices Market. As organizations strive to improve diagnostic procedures and enhance patient care, the latest analysis from Emergen Research offers valuable insights that are poised to revolutionize the biopsy devices market across various healthcare sectors. Biopsy devices are medical instruments or tools designed and used by healthcare...

Continue reading

Potato starch Market to Surpass 2.66 Billion by 2030 Drives Due to the rising clean label adoption

SkyQuest projects that the potato starch market will attain a USD 2.66 billion value by 2030, with a CAGR of 2.66% over the forecast period (2023-2030). The increasing demand for transparency in food products has led to rising clean-label adoption in the global potato starch market. Consumers’ preference for natural and easily recognizable ingredients drives manufacturers to offer cleaner and simpler labels, influencing the market’s trajectory. Westford, USA, Aug. 10, 2023 (GLOBE NEWSWIRE) — According to SkyQuest, the escalating consumer preference for quick and easy meal options has propelled the global potato starch market. This demand surge is driven by the convenience and versatility offered by processed foods, highlighting the need for increased potato starch production to cater to this trend. Browse in-depth TOC...

Continue reading

Fortune 1000 Company Awards IZEA Significant Contract

Managed Services Campaigns Will Aim to Drive Awareness, App DownloadsFortune 1000 Company Awards IZEA Significant ContractManaged Services Campaigns Will Aim to Drive Awareness, App DownloadsOrlando, Florida, Aug. 10, 2023 (GLOBE NEWSWIRE) — IZEA Worldwide, Inc. (NASDAQ: IZEA), the premier provider of influencer marketing technology, data, and services for the world’s leading brands and agencies, announced it has been awarded a mid-six-figure contract with a Fortune 1000 internet and technology company, a new client. IZEA’s Managed Services team will execute an influencer marketing campaign to drive brand awareness and encourage app downloads. “Influencer marketing is incredibly effective at driving consumer engagement, awareness, and action,” said Ted Murphy, IZEA Chairman and CEO. “Our research shows that half of U.S....

Continue reading

How Will the Cancer Diagnostics Market Transform Itself into a USD 311.19 Billion Powerhouse by 2032?

Rising prevalence of various types of cancer such as lung cancer and breast cancer across the globe is one of the major factors driving the cancer diagnostics market revenue growth Vancouver, Aug. 10, 2023 (GLOBE NEWSWIRE) — Emergen research is one of the pioneers in providing strategic insights for emerging and disruptive technologies which are supposed to show exponential growth in the near future., has released a report that delves deep into the dynamic landscape of the Cancer Diagnostics Market. As the healthcare landscape continues to evolve, the latest analysis from industry leader Emergen Research provides invaluable insights set to revolutionize cancer diagnostics strategies across the globe. Cancer diagnostics, a vital component of modern healthcare, encompasses the use of advanced technologies and data analysis to facilitate...

Continue reading

Orthopaedic Devices Market to Surpass 53.83 Billion by 2030 Drives Due to the Rising Disorders

SkyQuest projects that the orthopaedic devices market will attain a USD 53.83 billion value by 2030, with a CAGR of 3.1% over the forecast period (2023-2030). The surge in musculoskeletal ailments propels the global orthopaedic devices market. Increasing incidences of fractures, arthritis, and osteoporosis drive the demand for innovative devices, fostering market expansion while underlining the need for advanced medical solutions. Westford, USA, Aug. 10, 2023 (GLOBE NEWSWIRE) — According to SkyQuest, the escalating patient population afflicted by orthopaedic conditions fuels the growth of the global orthopedic devices market. As the number of individuals seeking treatment for musculoskeletal disorders rises, there is a corresponding demand for a diverse range of orthopaedic devices to cater to various medical needs. Browse in-depth...

Continue reading

How Will the Computer Vision Market Transform Itself into a USD 30.60 Billion Powerhouse by 2032?

Rapid advancements made in robots using vision-guided systems, rising demand for Electric Vehicles (EVs), and developments made in image sensors and image processing are some key factors driving the Computer Vision market revenue growth Vancouver, Aug. 10, 2023 (GLOBE NEWSWIRE) — Emergen research is one of the pioneers in providing strategic insights for emerging and disruptive technologies which are supposed to show exponential growth in the near future., has released a report that delves deep into the dynamic landscape of the Computer Vision Market. As organizations seek to enhance their procurement processes and streamline operations, Emergen Research’s latest analysis provides indispensable insights that are poised to revolutionize procurement strategies across industries. The Computer Vision Market revolves around the...

Continue reading

Track Group Reports 3rd Quarter Fiscal 2023 Financial Results

NAPERVILLE, Ill., Aug. 10, 2023 (GLOBE NEWSWIRE) — Track Group, Inc. (OTCQB: TRCK), a global leader in offender tracking and monitoring services, today announced financial results for its fiscal quarter ended June 30, 2023 (“Q3 FY23”). In Q3 FY23, the Company posted (i) total revenue of $8.7 Million (“M”), a decrease of approximately 3% over total revenue of $9.0M for the quarter ended June 30, 2022 (“Q3 FY22”); (ii) Q3 FY23 operating loss of ($0.3M) compared to Q3 FY22 operating loss of ($0.5M); and (iii) net loss attributable to common shareholders of ($0.7M) in Q3 FY23 compared to a net loss attributable to common shareholders of ($3.6M) in Q3 FY22. “While a relatively steady period of performance, the quarter ending June 30, 2023 saw improvements in revenue, adjusted EBITDA, operating loss and net loss attributable to common...

Continue reading

Stereotaxis Reports 2023 Second Quarter Financial Results

ST. LOUIS, Aug. 10, 2023 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the second quarter ended June 30, 2023. “Stereotaxis delivered 28% revenue growth in the quarter, driven by a healthy system pipeline and continued demand for our robotic technology,” said David Fischel, Chairman and CEO. “We received orders for two Genesis systems in the second quarter. System backlog of $16 million, multiple upcoming installations, and continued interest in our robotic technology support our expectation of annual double digit revenue growth.” “Stereotaxis continues to advance a robust innovation strategy. During the quarter we announced a significant strategic collaboration with Abbott to integrate the EnSite...

Continue reading

Kelso Technologies Inc. Financial Results for the Six Months Ended June 30, 2023

VANCOUVER, British Columbia and BONHAM, Texas, Aug. 10, 2023 (GLOBE NEWSWIRE) — Kelso Technologies Inc. (“Kelso” or the “Company”), (TSX: KLS), (NYSE American: KIQ) reports that it has released its unaudited consolidated interim financial statements and Management Discussion and Analysis for the six months ended June 30, 2023. The unaudited consolidated interim financial statements were prepared in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”). All amounts herein are expressed in United States dollars (the Company’s functional currency) unless otherwise indicated. The Company’s unaudited consolidated financial statements and MD&A for the six months ended June 30, 2023 were approved by the Board of Directors on August 09, 2023. SUMMARY...

Continue reading

Imperial Petroleum Inc. Reports Second Quarter and Six Months 2023 Financial and Operating Results

ATHENS, Greece, Aug. 10, 2023 (GLOBE NEWSWIRE) — IMPERIAL PETROLEUM INC. (NASDAQ: IMPP, the “Company”), a ship-owning company providing petroleum products, crude oil and dry bulk seaborne transportation services, announced today its unaudited financial and operating results for the second quarter and six months ended June 30, 2023. OPERATIONAL AND FINANCIAL HIGHLIGHTSFleet operational utilization of 75.4% in Q2 23’ with 28 days of technical off hire and 129 days of vessel repositioning. 68.5% of fleet calendar days equivalent to 734 days in Q2 23’ were dedicated to spot activity. Revenues of $59.0 million in Q2 23’ – up $47.7 million or 422.1% from Q2 22’. Net income of $16.8 million in Q2 23’ up by $16.7 million compared to Q2 22’. Adjusted Net income1 of $26.6 million in Q2 23’ up by $26.5 million compared to Q2 22’ or...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.